. ('rort.) and EDWAtlD C. COCKINt;S, M.r~., Ctt.B. I Much ~ been written m recent years of the relative advantages and chsadvantages of new intravenous anaesthetics. Such comparisons are always difficult to make because of the many variables which ca~Lnot be easily controlled in a clinical series. For that reason, we attempted some time ago to compare a number of intravenous agents in human vol~mteers, a&a~inistering each drug consecutively to the same individuals under rigidly controlled condittons (1, 2). Double the sleep dose of each drug was given in a standard concentration and at a standard rate. For a variety of reasons the results obtained did not necessarily reflect each agent's usefulness in clinical practice. The standardization of concentration is a procedure open to criticasm. Also, it is very difficdlt to deterrmne equi-potent doses for each agent and the administration of doable the sleep dose is not an exact criterion since the sleep dose itself is hard to define. It was felt that a htrther controlled study should be undertaken, restricting the administration of each agent to patients undergoing a standard operative; procedure and using as the criterion of dosage the amount of drug req~Lired t:o permit the performance of the operation. The concentrations used in this study were the ones commonly employed in the chnical use of these agents.
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It was ho-Jed that the present clinical study would )4elcl additional information which wou_d enhance the value of our previous e,vperimental, results when considered side by side with them.
METHOD
As in previous clinical studies of intravenous a~aaesthetics (3, 4) the drugs were administered for minor gynaecological procedures only and their use was limited to patients in physical status 1 and 2. Freshly prepared 2.~ per cent solutions of thiopental and methitural and 10 per cent solutions of buthalitone and hexobarbital were used. These concentrations are the ones used commonly in clinical practice. Anaesthesia was maintained by intermittent injection The patients received oxygen by mask in a semi-closed system at a flow of 6 L per minute. Muscle relaxants were given only when muscle relaxation for pelvic examination was inadequate. A1 patients were premeditated with meperidine 50 mg. and atropine 0.4 mg intramuscularly. Fifty patients were studied in each series. Each drug was compared with thiopental and a htrther comparison was WYANT ET AL.: THIOPENTAL AND OTHER INTIiAVENOUS AGENTS 109, made between metl~iture~ and buthalitone because these two agents are said to have some properties in common. Hence the methitural series is included in the prqsent study although it has been published previously (3).
r)ISGUSSION OF RESULTS
Age, height, and weight (Tables I and II) . Differences in file four compai'isons were statistically not significant. Hence, the four groups are comparable as far as age, height, and weig_at are concerned. Time from premedication to induction of anaesthesia (Tahde iII). There was the usuaI wide variation in the time from premedication to induction. Only in the comparison of thiopental with, methitural is the difference of the mean (Tables IV and V) . Slgmfieant or almost significant differences were apparent in the thiopental-methitural and thiopentalbuthalitone comparisons only. In the comparisons between thlopental and hexobarbital and between methitural and buthalitone, no such significant differences existed. Comparisons. Thlopental/Methltural, t = 3 088"*, Thlopenl:al/Bulhahtone, t = 2 370", Thtopental/Hexobarbltal, t = 840, Methltural/Buthahtone, t = --0 667 S D. = Standard Devlatlon *Sig. (P < 05) **H.S. (P < 01)
Duration of anaesthesia and operation
Total anaesthetic dose ( Table' VI) The differences m all four comparisons were statistically highly significant. Compar,sons: Thlopental/Methltural, t = -12.183"*; Thiopental/ Buthahtone, t = --16 899**, Thlopental/Hexobarbital, t = --13 503** Methltural/Buthahtone, t -----8 262**. S D --Standard Deviation **HS (P < 01).
Induction and maintenance doses (Tables VII and VIII). Significant d~fferences
existed in all four comparisons as far as the reduction dose was concerned. The differences in the maintenance dose were stahsfically significant for the three comparisons wlth sodium thiopental, but the difference of ~Le mean maintenance dose of buthalitone as compared with methiturM was not significant. 
Com?ar, sons
ButhaLtone, t---21291**, Thlopental/Hexobarbltal, Methltural/Buthahtone, t = -10 287** S D = Standard Dewatmn **H.S (P < 01) Com?amsons Thmpental/Methltural, t = -8 192"*! Buthal_tone, t = -ll 659"*, Thlol~ental/Hexobarbltal, Methltural/Bu{hahtone, t = --0 586 S D = Standard Dewatmn **HS (P < 01)
TMopental/ t = 9 977"*, (Table IX) . Because of the significant difference m the mean durahon of anaesthesia in the thiopental-methitural comparison and the almost slgn:tflcant difference m the tlfiopental-buthalitone Compartsons TMopental / Meth~tta'al, t = -10 384"*, Thlopental/Buthahtone, t = --14 065"*, Thiopental/Hexobarbltal, t ----9 580**, Mcthltural/But]hahtone, t = --5 278**.
Dose per minute of anaesthesia
S D = Standard Dewahon. **HS (-P < 01)
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CANADIAN ANAESTHETISTS" SOCIE'I'x" JOURNAL comparison, the dose required per minute o{ anaesthesia was calculated. The differences in all four comparisons were highly significant. They indicated that thiopental was about twice as potent as any of the other three with methitural, hexobarbital, and buthalitone fairly close together in order of decreasing potency.
Total sleep time (Table X) This was defined as the time between induction of anaesthesia and the patient's purposeful response to verbal command. The differences in the thiopental-hexobarbital comparisons were statistically highly significant whereas the remaining three comparisons were not significant. This indicates that for a standard operative procedure there is no difference in the sleep time after thiopental, methitural, or buthalitone, whereas awakening following hexobarbital anaesthesia is greatly delayed. Comparisons Thmpental/baethitural, t = 1 155, Thiopental/Buthahtone, t ---0 340, Thiopental/Hexobarbital, t = --6 252**, Methltural/Buthahtone, t ----1 351 S.D. =-Standard Dewation. **HS (P <'01). (Table XI ) . This was the period from the last injection until the time when the patient responded to verbal command. AgMn, differences were statistically significant only in the thiopental-hexobarbital comparison and it is, therefore, concluded that hexobarbltal has the longest action of the four agents studied. The other three agents have a very similar duration of action under the conditions of this study (Table XII) . The differences in all tour comparisons were statistically highly significant. Because of the prolonged sleep after hexobarbital, the sequence here is thiopental, hexobarbital, methi~ral, buthalitone. Compari.sons
Waking time from last injection

Dose per minute of sleep time
Thmpental / Methltural, t = -6 709**; Thmpental/Buthahtone, t = -8 360**, Thmpental/Hexobarbital, t = -2 576"*, Methltural/Buthalitone, t = --5 071"* S D. = Standard Devlatmn **HS (P < 01)
Side effects (Table XIII) . There was no significant difference between the incidence of cough m the thiopental-buthalitone and thiopental-hexobarbital comparisons With methitm'al, the incidence during induction and maintenance was significantly higher than with either of the other three agents.
On the other hand the incidence of hiccough was greatest with buthalitone.
There was no significant statistical difference between thiopental and methitural With hexobarbital, hiccough was rare 
Com paY~s ons
"Thiopental/Methltural t = --2.866** Thlopental/Buthahtone t = -0 392 Thlopental/Hexobarbltal t = 1.026 Methitural/Buthalitone t = 2 000" S D = Standard Devlanon *Sig (P < 05"1 **HS (P < (1). t = --1.581 t = --1282 t = --4 524** t = 0 455 t = 2 000" t = 4 000"* t = --2 796** t = 1 750
Movements occurred in many patients in all three groups. This was because slight movements were used[ as an indication for additional amounts of drug and may, therefore, be ignored for purposes of evaluation. Movements involving the legs to the point where such movements were noticed by the surgeon were 114 CANADIAN ANAESTHETISTS' SOCIETY JOUIt]q'M_~ classified as moderate. Gross movements involved the entire body and included withdrawal of the pelvis. No such moderate or gross movements were seen under thiopental anaesthesia, but there was a significant incidence olF these with both buthalitone and methltural, and they occttrred in the majority of patients receiving hexobarbital (Table XIV) . These severe movements could not always be adequately controlled by increasing the dose of the drug Apnoea (Table XV) . The incidence of apnoea s an induction dose of thiopental was very high, significantly less so with rnetIntural, even less so with buthalitone and least with hexobarbital A similar ~relation applied to the mean duration of apnoea, this was longest w~th thiopental and shortest l wlth hexobarbital. 
Comparisons
Thiopental/Methitural t = 4 622** Thiopental/Buthahtone t --7 368** Thiopental/Hexobarbltal t --10 746** Methltural/Buthahtone t = 2 041" S D --Standard Deviation. *Sig. (P < 05) **H S. (P < 01) muscuIar relaxation was inadequate for proper bimanual pelvic examination. From the analysis of the data, it would appear tl~at both methitural and hexobarbital tend to relax slightly the lower abdominal muscles since relaxants were infrequently needed with these two drugs. The differences between them and thiopental were significant. The difference between thiopent~d and buthalitone was statistically not significant. Compamsons" Thlopental/Methltuml, t = 3 377**, Thlopental./Buthahtone, t---1 562, Thmpen~al / He~obarbltal, t = 4 167"*, Methatural/Buthahtone, t = -3 137"*.
S D = Standard Devmtmn **H.S (P < 01) i
Emergence from anaesthesia (Table XVII) . Hiccough was entirely absent after buthalitone, thiopental, and hexobarbital, but was rel~,txvely common after methitural. On the other hand, the incidence of nausea and w~miting was very high after hexobarbital. They occurred much less frequently following admin~s-trataon of the other three agents, with thiopental causing these reactions somewhat more frequently than the remaining two drugs. 
Recovery period (Table XVIII ) . The incidence of post-anaesthetic nausea and emesis was relatively high ~ffter hexobarbital, lasting frequently as long as twelve hours. Three pal:tents each ekperiienced vertigo and headache following the drug. Two patients complained of headache following buthalitone and six others had vertigo Drowsiness and tirednes~ were complained of "by a small number of patients after thiopental, methltural, and buthalitone. 
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S~Y
The claim that some of the newer barbiturates have a shorter duration than older agents has not been borne out by the present investigation in regard to thiopental, but is true in regard to sodium hexobarbital. If sodium thiopental, sodium buthalitone, or sochum methitural is used as the sole agent for a standard operative procedure, the least amount which will keep the patient quiet on the table being administered, there is no difference m the total sleep time or in the waking tame from the last injection. If dose per minute of anaesthesia for such a standard procedure is taken as an indication, the relative potency of the four agents studied is: thiopental, 1; methitural, 0.5, hexobarbital, 0.4; and buthalitone, 0.35. q2ae most potent agent shows the highest incidence of apnoea following induction and the longest mean duration of apnoea; the less potent ones have a lower incidence and a shorter mean duration of apnoea.
The incidence of cough during induction and maintenance is very much greater with methitural than with the other three drugs, w!hereas the incidence of hiccough during maintenance is much greater with buthalitone than with the WYANT ET AL.: THIOPENTAL AND OTHER INTRAVENOUS AGENTS 117 other three drugs. The incidence of moderate and gross movements following sodium hexobarbital is ,very high indeed. Sodium thiopental appears the most predictable and reliable of the four drugs, and it is invariably possible to control slight movements of patients ,and thus maintain smooth anaesthesia. With the other three drugs this is not always possible, and with sodin~a hexobarbital it is rarely possible, even when the amount of drug administered is markedly increased. Sodium methitural and sochum hexobarbital are the only ones which seem to relax abdominal muscles shghtly This action reduces the need for relaxants for bimanual pelvic examination considerably compared with the other two drugs.
In the post-anaesthetic period hiccough is again a relatively frequent phenomenon after methitural anaesthesia and nausea and vomiting are very common following hexobarbital. &fter lbuthalitone and hexobarbitaI dizziness and headache are more frequently seen than after the other two agents.
In summary, it appears that sufficiently large doses of the inherently shorteracting methitural and buthalitone are required for smooth anaesthesia, so that total sleep time is in the end no different from thiopental. Anaesthesia is neither as smooth nor as predictable and free from annoying minor side effects as it is when thiopental is used. These disadvantages outweigh the shorter post-induction apnoea with methi~ral and buthalitone. The very high incidence of movements during anaesthesia, the long postoperative sleep and the high incidence of nausea and emesis in the post-anaesthetic period far outweigh the low incidence and duration of post-induction apnoea' following sodium hexobar[,tal anaesthesia.
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P&stn~
Nous avons administrfi, en doses fractiorm6eA, ~ einquante femmes en sant~ qni devaient subir des op~ratlons gyn~eologiques mineures, du thiopenthal de ~odium (Pentothal| du methitural de sodium (Neraval| du buthalitone de sodium (TransithaI| at de rhexobarhital de sodium (EvipaI| Nous avons compar$ le methitural de sodium, le buthalitone de sodium et l'hexobarhtal de sodium avec le thiopental de .,;odium et le methitural de sodium avec le buthalitone de sodium. Nous avons emp]oyfi des solutions ~t 2~_' % pour le thiopental et le methitural et des solutions k 10~ pour le buthalitone et l'hexobarbital. Nous avons obser% que, ]..',our une operation ordinaire r6guli~re, si nous employons, comme seul agent, le thiopental, le buthalitone" ou le methitural, la dur6e totale du sommeil pour chaeun des agents Stait la m,~me. Apr~s l'e~aploi de rhexobarbital, la durSe du sommeil est beaueoup plus longue. Le pouvoir relatif des trois agents est: le thiopental, 1, le methitural, 0 5; lqaexobarbital, 0.4; 118 CANADIAN ANAESTHETISTS" SOCIETY JOUflNAL et le buthalitone, 0.35. En ce qui concerne l'appantion et la durge d'apn6e, le thiopental se classe premier et l'hexobarbital dernier. L e plus fiable des quatre agents ~tudi6s a ~t6 le thiopental; nous 'avons r(ussi avec lui ~t maintemr une douce anesth6sie, ce que nous ne pouvons pas ckre des trois autres. Nous avons not6 de la toux plus souvent avee le methitural qu'avec les deux autres agents, du hoquet plus souvent avec le buthahtone et des mouvements de route amplitude durant l'anesth6sle ~t l'hexobarbltal. Nous avons observ~ un 16ger effet myor6-solutif sur les muscles de rabdomen irff~rieur avec le rnethttural et l'hexobarbital de sodmm et non pas avee le thiopental et le buthalitone. Apr~s l'anesth~sie, Ie hoquet est relativement-plus fr6quent avec ]e rriethitural et, apr~s l'hexobarbital, il y a plus de naus~es et de vomlssements. Aprgs le butJaalitone et lqaexobarbital, nous avons observ6 trbs souvent de la c@hal~e et des 6tourchssements.
